Form 8-K - Current report:
SEC Accession No. 0001477932-26-001176
Filing Date
2026-03-05
Accepted
2026-03-05 07:49:12
Documents
15
Period of Report
2026-03-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K aspi_8k.htm   iXBRL 8-K 26683
2 PRESS RELEASE aspi_ex991.htm EX-99.1 13042
  Complete submission text file 0001477932-26-001176.txt   162823

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aspi-20260305.xsd EX-101.SCH 5022
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aspi-20260305_lab.xml EX-101.LAB 15213
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aspi-20260305_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aspi-20260305_pre.xml EX-101.PRE 9640
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aspi-20260305_def.xml EX-101.DEF 2099
17 EXTRACTED XBRL INSTANCE DOCUMENT aspi_8k_htm.xml XML 3534
Mailing Address 2200 ROSS AVENUE, SUITE 4575E DALLAS TX 75201
Business Address 2200 ROSS AVENUE, SUITE 4575E DALLAS TX 75201 202-756-2245
ASP Isotopes Inc. (Filer) CIK: 0001921865 (see all company filings)

EIN.: 872618235 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41555 | Film No.: 26724224
SIC: 2890 Miscellaneous Chemical Products
(CF Office: 08 Industrial Applications and Services)